Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T0BF
|
|||
| Former ID |
DIB008878
|
|||
| Drug Name |
EBV CTLs
|
|||
| Synonyms |
EBV CTLs (EBV-associated lymphoma, nasopharyngeal carcinoma); Epstein-Barr virus cytotoxic T lymphocytes, Baylor College/ Cell Medica; Epstein-Barr virus specifc T cells, St Jude/Baylor; Immunotherapy (EBV-associated lymphoma), St Jude/Baylor; EBV CTLs (EBV-associated lymphoma, nasopharyngeal carcinoma), Baylor College/ Cell Medica
Click to Show/Hide
|
|||
| Indication | Lymphoma [ICD-11: 2A80-2A86; ICD-9: 202.8, 208.9] | Phase 1/2 | [1] | |
| Company |
St Jude Children's Research Hospital
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | T-cell therapy using a bank of EBV-specific cytotoxic T cells: lessons from a phase I/II feasibility and safety study. J Immunother. 2014 Apr;37(3):170-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.